Livola

Livola

l-ornithine-l-aspartate

Manufacturer:

Landson
Concise Prescribing Info
Contents
L-ornithine-L-aspartate
Indications/Uses
Reducing plasma ammoniac level in condition of hyperammonemia as a result of acute & chronic liver disease eg, liver cirrhosis, fatty liver, hepatitis especially in the treatment of pre-coma or neurological complications (hepatic encephalopathy).
Dosage/Direction for Use
Granules for oral soln 3 sachet/day. Inj 4 amp/day. Pre-coma or coma 8 amp may be given w/in 24 hr depending on the severity of the condition. Max infusion rate: 5 g/hr.
Administration
Should be taken with food.
Contraindications
Oral soln/inj: Severe renal impairment. Inj: Administration via artery.
Special Precautions
Monitor serum & urine urea levels at high doses. Impaired liver function. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Mild to moderate vomiting, nausea, sensation of heat & palpitation.
MIMS Class
Cholagogues, Cholelitholytics & Hepatic Protectors
ATC Classification
A05BA06 - ornithine oxoglurate ; Belongs to the class of drugs used in liver therapy.
Presentation/Packing
Form
Livola granule for oral soln 3 g
Packing/Price
10 × 1's (Rp360,000/boks)
Form
Livola inj 500 mg
Packing/Price
(amp) 10 mL x 5 × 1's (Rp450,000/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in